ALX Oncology
ALXO
#9346
Rank
NZ$0.25 B
Marketcap
NZ$1.94
Share price
3.92%
Change (1 day)
-23.91%
Change (1 year)

Earnings for ALX Oncology (ALXO)

Earnings in 2026 (TTM): -NZ$0.14 Billion

According to ALX Oncology's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.19 Billion, an increase over its 2024 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ALX Oncology from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.14 Billion-24.56%
2025 -NZ$0.19 Billion-24.81%
2024 -NZ$0.25 Billion-16.4%
2023 -NZ$0.3 Billion27.41%
2022 -NZ$0.23 Billion49.61%
2021 -NZ$0.16 Billion86.94%
2020 -NZ$81.69 Million132.9%
2019 -NZ$35.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 96.44%๐Ÿ‡บ๐Ÿ‡ธ USA